Horizon source briefing
DHA: New Facility License
Inactive facility-licence sequence, five-day target, NABIDH prerequisite, activation and inspection boundary
Healthcare & Life Sciences in United Arab Emirates: independent market-entry study
What the source contributes
Inactive facility-licence sequence, five-day target, NABIDH prerequisite, activation and inspection boundary
Horizon synthesis and use
- Evidence used in the Healthcare & Life Sciences in United Arab Emirates: independent market-entry study country-sector decision dossier. Recheck the original publication date, definition and current status before transaction-specific use.
Before using the evidence
Four questions that keep the conclusion honest
- 01Which registration, procurement-plan, tender, opening, prequalification or award stage does “DHA: New Facility License” evidence?
- 02What tender-specific eligibility, foreign-participation, licence, technical, financial, security or bid-bond requirements remain outside this record?
- 03Does the source establish an accessible opportunity for Healthcare & Life Sciences in United Arab Emirates: independent market-entry study, or only portal access, a whole-system count or a completed procurement stage?
- 04The record was reviewed on 2026-10-14; what has DHA: New Facility License changed or superseded since that date?
Where Horizon integrates this source